Please assess the completion status of the following clinical trial:

Trial Title: A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with a history of systemic diabetes (type I or II)~* Subject with a documented history of Non Proliferative Diabetic Retinopathy (NPDR)~* Subjects with no PVD at baseline exam in the study eye.~Exclusion Criteria:~* Subjects with Retinal pathology in the study eye other than (NPDR)~* Subjects with high myopia in the study eye~* Subjects who have monocular vision or contra lateral vision of 20/200 or worse BCVA in the non-study eye.~* Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less than 6 months prior to study enrollment~* Subjects that have had either vitrectomy surgery, intravitreal injections, or laser treatments in the study eye.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).